{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:18:19Z","timestamp":1768457899597,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW007124"],"award-info":[{"award-number":["D43TW007124"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>In preparation for the National Hepatitis C Elimination Program in the country of Georgia, a nationwide household-based hepatitis C virus (HCV) seroprevalence survey was conducted in 2015. Data were used to estimate HCV genotype distribution and better understand potential sex-specific risk factors that contribute to HCV transmission. HCV genotype distribution by sex and reported risk factors were calculated. We used explanatory logistic regression models stratified by sex to identify behavioral and healthcare-related risk factors for HCV seropositivity, and predictive logistic regression models to identify additional variables that could help predict the presence of infection. Factors associated with HCV seropositivity in explanatory models included, among males, history of injection drug use (IDU) (aOR = 22.4, 95% CI = 12.7, 39.8) and receiving a blood transfusion (aOR = 3.6, 95% CI = 1.4, 8.8), and among females, history of receiving a blood transfusion (aOR = 4.0, 95% CI 2.1, 7.7), kidney dialysis (aOR = 7.3 95% CI 1.5, 35.3) and surgery (aOR = 1.9, 95% CI 1.1, 3.2). The male-specific predictive model additionally identified age, urban residence, and history of incarceration as factors predictive of seropositivity and were used to create a male-specific exposure index (Area under the curve [AUC] = 0.84). The female-specific predictive model had insufficient discriminatory performance to support creating an exposure index (AUC = 0.61). The most prevalent HCV genotype (GT) nationally was GT1b (40.5%), followed by GT3 (34.7%) and GT2 (23.6%). Risk factors for HCV seropositivity and distribution of HCV genotypes in Georgia vary substantially by sex. The HCV exposure index developed for males could be used to inform targeted testing programs.<\/jats:p>","DOI":"10.1371\/journal.pone.0262935","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T19:08:05Z","timestamp":1642792085000},"page":"e0262935","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk factors and genotype distribution of hepatitis C virus in Georgia: A nationwide population-based survey"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-3325","authenticated-orcid":true,"given":"Davit","family":"Baliashvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Averhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Kasradze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-2006","authenticated-orcid":true,"given":"Stephanie J.","family":"Salyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgi","family":"Kuchukhidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amiran","family":"Gamkrelidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paata","family":"Imnadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-2308","authenticated-orcid":true,"given":"Maia","family":"Alkhazashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gvantsa","family":"Chanturia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6910-5447","authenticated-orcid":true,"given":"Nazibrola","family":"Chitadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roena","family":"Sukhiashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Blanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Drobeniuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesl M.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"pone.0262935.ref001","unstructured":"World Health Organization. Global hepatitis report 2017. Geneva: 2017 April 2017. Report No."},{"issue":"3","key":"pone.0262935.ref002","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"The lancet Gastroenterology & hepatology"},{"issue":"9973","key":"pone.0262935.ref003","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","article-title":"Hepatitis C","volume":"385","author":"DP Webster","year":"2015","journal-title":"Lancet"},{"issue":"28","key":"pone.0262935.ref004","first-page":"9270","article-title":"Epidemiology and natural history of hepatitis C virus infection","volume":"20","author":"MH Lee","year":"2014","journal-title":"World journal of gastroenterology"},{"issue":"4","key":"pone.0262935.ref005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1601-0825.2005.01076.x","article-title":"Transmission of hepatitis C virus by saliva?","volume":"11","author":"MC Ferreiro","year":"2005","journal-title":"Oral Dis"},{"issue":"2","key":"pone.0262935.ref006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1348-0421.1994.tb01758.x","article-title":"Greater amount of HCV-RNA in tears compared to blood","volume":"38","author":"HH Feucht","year":"1994","journal-title":"Microbiol Immunol"},{"issue":"5","key":"pone.0262935.ref007","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/jiu550","article-title":"A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals","volume":"211","author":"D Bradshaw","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0262935.ref008","first-page":"297","article-title":"The Investigation of HCV RNA in Tear Fluid and Aqueous Humor in Patients with Anti-HCV Antibody Positive Who Underwent Cataract Surgery","volume":"24","author":"M Atas","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"pone.0262935.ref009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrgastro.2013.179","article-title":"HCV transmission in industrialized countries and resource-constrained areas","volume":"11","author":"M Thursz","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"pone.0262935.ref010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0962280208094691","article-title":"An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales","volume":"18","author":"D De Angelis","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"pone.0262935.ref011","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijid.2014.02.003","article-title":"Risk factors associated with high prevalence rates of hepatitis C infection in Egypt","volume":"25","author":"C Reker","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"12","key":"pone.0262935.ref012","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1007\/s10620-005-3061-3","article-title":"Hepatitis C virus risk factors in the Turkish community","volume":"50","author":"B Yildirim","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"4","key":"pone.0262935.ref013","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1017\/S0950268811001087","article-title":"Prevalence and risk factors for hepatitis C virus infection in Kech District, Balochistan, Pakistan: most infections remain unexplained. A cross-sectional study","volume":"140","author":"F Ahmed","year":"2012","journal-title":"Epidemiology and infection"},{"issue":"5","key":"pone.0262935.ref014","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2893.2009.01230.x","article-title":"Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan","volume":"17","author":"NZ Janjua","year":"2010","journal-title":"J Viral Hepat"},{"issue":"6","key":"pone.0262935.ref015","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4269\/ajtmh.17-0019","article-title":"Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan","volume":"97","author":"A Trickey","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"pone.0262935.ref016","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"L Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0262935.ref017","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.26164","article-title":"Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study","volume":"57","author":"NA Terrault","year":"2013","journal-title":"Hepatology"},{"key":"pone.0262935.ref018","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2016.05.030","article-title":"Sexually acquired hepatitis C virus infection: a review","volume":"49","author":"DP Chan","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pone.0262935.ref019","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"DB Smith","year":"2014","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"pone.0262935.ref020","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"E Gower","year":"2014","journal-title":"J Hepatol"},{"key":"pone.0262935.ref021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13027-016-0099-0","article-title":"Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe","volume":"11","author":"A Petruzziello","year":"2016","journal-title":"Infectious agents and cancer"},{"key":"pone.0262935.ref022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2016.05.010","article-title":"New findings in HCV genotype distribution in selected West European, Russian and Israeli regions","volume":"81","author":"V Kartashev","year":"2016","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"issue":"8","key":"pone.0262935.ref023","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3748\/wjg.14.1237","article-title":"Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006","volume":"14","author":"F Roman","year":"2008","journal-title":"World journal of gastroenterology"},{"issue":"3","key":"pone.0262935.ref024","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12889-019-6784-3","article-title":"Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination","volume":"19","author":"LM Hagan","year":"2019","journal-title":"BMC Public Health"},{"issue":"41","key":"pone.0262935.ref025","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.15585\/mmwr.mm6541a2","article-title":"National Progress Toward Hepatitis C Elimination\u2014Georgia, 2015\u20132016","volume":"65","author":"L Gvinjilia","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"pone.0262935.ref026","doi-asserted-by":"crossref","first-page":"773","DOI":"10.15585\/mmwr.mm6629a2","article-title":"The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination\u2014Georgia, 2015\u20132016","volume":"66","author":"M Nasrullah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"28","key":"pone.0262935.ref027","doi-asserted-by":"crossref","first-page":"753","DOI":"10.15585\/mmwr.mm6428a2","article-title":"Launch of a Nationwide Hepatitis C Elimination Program\u2014Georgia, April 2015","volume":"64","author":"K Mitruka","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"pone.0262935.ref028","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal diagrams for epidemiologic research","volume":"10","author":"S Greenland","year":"1999","journal-title":"Epidemiology"},{"key":"pone.0262935.ref029","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-1742-3","volume-title":"Logistic Regression: A Self-Learning Text","author":"D Kleinbaum","year":"2010","edition":"3"},{"key":"pone.0262935.ref030","article-title":"Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program","author":"EM Bloch","journal-title":"Transfusion"},{"issue":"2","key":"pone.0262935.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148343","article-title":"The Increasing Trend in Caesarean Section Rates: Global, Regional and National Estimates: 1990\u20132014","volume":"11","author":"AP Betr\u00e1n","year":"2016","journal-title":"PloS one"},{"key":"pone.0262935.ref032","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13011-016-0049-2","article-title":"Policing, massive street drug testing and poly-substance use chaos in Georgia\u2014a policy case study","volume":"11","author":"D Otiashvili","year":"2016","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"165","key":"pone.0262935.ref033","first-page":"71","article-title":"Prevalence of HCV and genotypes distribution in general population of Georgia","author":"L Sharvadze","year":"2008","journal-title":"Georgian medical news"},{"issue":"2","key":"pone.0262935.ref034","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11524-006-9032-y","article-title":"Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T\u2019bilisi, Republic of Georgia","volume":"83","author":"K Stvilia","year":"2006","journal-title":"J Urban Health"},{"issue":"2","key":"pone.0262935.ref035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12072-016-9776-8","article-title":"Sofosbuvir\/velpatasvir: a pangenotypic drug to simplify HCV therapy","volume":"11","author":"R Lee","year":"2017","journal-title":"Hepatol Int"},{"issue":"5","key":"pone.0262935.ref036","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14656566.2017.1282459","article-title":"A pangenotypic, single tablet regimen of sofosbuvir\/velpatasvir for the treatment of chronic hepatitis C infection","volume":"18","author":"IS Weisberg","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"pone.0262935.ref037","doi-asserted-by":"crossref","first-page":"102893","DOI":"10.1016\/j.drugpo.2020.102893","article-title":"Integration of hepatitis C treatment at harm reduction centers in Georgia-Findings from a patient satisfaction survey","volume":"84","author":"M Butsashvili","year":"2020","journal-title":"The International journal on drug policy"},{"key":"pone.0262935.ref038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.puhe.2021.03.017","article-title":"Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia","volume":"195","author":"K Stvilia","year":"2021","journal-title":"Public Health"},{"issue":"1","key":"pone.0262935.ref039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijid.2007.04.015","article-title":"Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients","volume":"12","author":"MH Kuniholm","year":"2008","journal-title":"Int J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T19:08:42Z","timestamp":1642792122000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262935"}},"subtitle":[],"editor":[{"given":"Jason T.","family":"Blackard","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0262935","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]}}}